Former Investment Manager at Norrsken Impact Fund
Check size: Historical Norrsken role. The firm now publishes €1M–€10M tickets, but no personal ticket or present investing authority should be inferred because Christian left for an operating role in 2026.
During his Norrsken tenure, Christian explored frontier technologies where difficult physical environments create enabling infrastructure for Earth: satellites for climate intelligence, microgravity for drugs, semiconductors and materials, and in-space supply chains. His move to Biorce shifts his current work from capital allocation to operating an AI clinical-trial platform.
Do not route an investment pitch to Christian as a current Norrsken decision-maker. For Norrsken, use investments@norrsken.vc. Contact him only where directly relevant to Biorce's clinical-trial mission or his historical space/climate expertise, and acknowledge his current operating role.
Historically, enabling technologies with concrete benefits on Earth, falling-cost curves, large infrastructure implications and teams capable of executing hard science or hardware. His current operating move suggests particular interest in companies where AI can shorten high-value, regulated workflows such as clinical trials.
He is no longer accepting pitches as a Norrsken investor. Historical inference: speculative space projects without a terrestrial use case, hardware without a cost-down path, and climate claims unsupported by deployment evidence.
Evaluate a space technology by the concrete climate, connectivity, healthcare, manufacturing or sensing outcome it enables on Earth.
Require falling launch or production costs, an executable supply chain and a credible deployment path before treating a frontier-hardware opportunity as venture-scalable.
Satellites, microgravity manufacturing and eventually in-space supply chains can make space an enabling layer for climate intelligence and more sustainable industry on Earth.